Identification of reduced circulating haptoglobin concentration as a biomarker of the severity of pulmonary embolism: A nontargeted proteomic study

PLoS ONE

Volumn 9, Issue 6, 2014, Pages

  Insenser, María ^a   Montes Nieto, Rafael ^a   Martínez García, M Ángeles ^a   Durań, Elena Fernandez ^a   Santiuste, Carmen ^b   Goḿez, Vicente ^b   Kline, Jeffrey A ^c   Escobar Morreale, Héctor F ^a   Jimeńez, David ^a  

^a UNIVERSITY OF ALCALÁ   (Spain)

^b HOSPITAL RAMÓN Y CAJAL   (Spain)

^c INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 MACROGLOBULIN; BIOLOGICAL MARKER; HAPTOGLOBIN; HEMOPEXIN; IMMUNOGLOBULIN ALPHA 1 CHAIN C; UNCLASSIFIED DRUG; IMMUNOGLOBULIN HEAVY CHAIN; PROTEOME;

AGED; ARTICLE; CLINICAL ARTICLE; DISEASE SEVERITY; FEMALE; HIGH RISK PATIENT; HUMAN; INTERMEDIATE RISK PATIENT; LOW RISK PATIENT; LUNG EMBOLISM; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEOMICS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; TWO DIMENSIONAL DIFFERENCE GEL ELECTROPHORESIS; BLOOD; MASS SPECTROMETRY; METABOLISM; PATHOLOGY; PROGNOSIS; PULMONARY EMBOLISM; RISK; SEVERITY OF ILLNESS INDEX; TWO DIMENSIONAL GEL ELECTROPHORESIS; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALPHA-MACROGLOBULINS; BIOLOGICAL MARKERS; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEMALE; HAPTOGLOBINS; HEMOPEXIN; HUMANS; IMMUNOGLOBULIN ALPHA-CHAINS; MALE; PROGNOSIS; PROTEOME; PULMONARY EMBOLISM; RISK; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 84903650115     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0100902     Document Type: Article

References (34)

1. Cohen AT, Agnelli G, Anderson FA, Arcelus JI, Bergqvist D, et al. (2007) Venous thromboembolism (VTE) in Europe. The number of VTE events and associated morbidity and mortality. Thromb Haemost 98: 756-764.
2. The Columbus Investigators (1997) Low-molecular-weight heparin in the treatment of patients with venous thromboembolism. N Engl J Med 337: 657-662.
3. Goldhaber SZ, Visani L, De Rosa M (1999) Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). Lancet 353: 1386-1389.
4. Douketis JD, Kearon C, Bates S, Duku EK, Ginsberg JS (1998) Risk of fatal pulmonary embolism in patients with treated venous thromboembolism. JAMA 279: 458-462.
5. Buller HR, Davidson BL, Decousus H, Gallus A, Gent M, et al. (2003) Subcutaneous fondaparinux versus intravenous unfractionated heparin in the initial treatment of pulmonary embolism. N Engl J Med 349: 1695-1702.
6. Conget F, Otero R, Jimenez D, Marti D, Escobar C, et al. (2008) Short-term clinical outcome after acute symptomatic pulmonary embolism. Thromb Haemost 100: 937-942.
7. Kearon C, Kahn SR, Agnelli G, Goldhaber S, Raskob GE, et al. (2008) Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 133: 454S-545S.
8. Tapson VF (2008) Acute pulmonary embolism. N Engl J Med 358: 1037-1052.
9. Jimenez D, Yusen RD, Otero R, Uresandi F, Nauffal D, et al. (2007) Prognostic models for selecting patients with acute pulmonary embolism for initial outpatient therapy. Chest 132: 24-30.
10. Jimenez D, Yusen RD (2008) Prognostic models for selecting patients with acute pulmonary embolism for initial outpatient therapy. Curr Opin Pulm Med 14: 4142421.
11. Verrills NM (2006) Clinical proteomics: present and future prospects. Clin Biochem Rev 27: 992116.
12. Issaq HJ, Veenstra TD, Conrads TP, Felschow D (2002) The SELDI-TOF MS approach to proteomics: protein profiling and biomarker identification. Biochem Biophys Res Commun 292: 587-592.
13. Coombes KR, Morris JS, Hu J, Edmonson SR, Baggerly KA (2005) Serum proteomics profiling-a young technology begins to mature. Nat Biotechnol 23: 2912292.
14. PIOPED Investigators (1990) Value of the ventilation/perfusion scan in acute pulmonary embolism. Results of the prospective investigation of pulmonary embolism diagnosis (PIOPED). JAMA 263: 2753-2759.
15. Kearon C, Ginsberg JS, Hirsh J (1998) The role of venous ultrasonography in the diagnosis of suspected deep venous thrombosis and pulmonary embolism. Ann Intern Med 129: 1044-1049.
16. Remy-Jardin M, Remy J, Wattinne L, Giraud F (1992) Central pulmonary thromboembolism: diagnosis with spiral volumetric CT with the single-breathhold technique-comparison with pulmonary angiography. Radiology 185: 381-387.
17. Jimenez D, Lobo JL, Monreal M, Moores L, Oribe M, et al. (2014) Prognostic significance of multidetector CT in normotensive patients with pulmonary embolism: results of the protect study. Thorax 69: 109-115.
18. Blum H, Beier H, Gross HJ (1987) Improved silver staining of plant proteins, RNA and DNA in polyacrylamide gels. Electrophoresis 8: 93-99.
19. Insenser M, Martínez-García MÁ, Montes Nieto R, San-Millán JL, Escobar-Morreale HF (2010) Impact of the storage temperature on human plasma proteomic analysis: Implications for the use of human plasma collections in research. Proteomics Clin Appl 4: 739-744.
20. Insenser M, Martinez-Garcia MA, Montes R, San-Millan JL, Escobar-Morreale HF (2010) Proteomic analysis of plasma in the polycystic ovary syndrome identifies novel markers involved in iron metabolism, acute-phase response, and inflammation. J Clin Endocrinol Metab 95: 3863-3870.
21. Insenser M, Montes-Nieto R, Vilarrasa N, Lecube A, Simo R, et al. (2012) A nontargeted proteomic approach to the study of visceral and subcutaneous adipose tissue in human obesity. Mol Cell Endocrinol 363: 10-19.
22. Dati F, Schumann G, Thomas L, Aguzzi F, Baudner S, et al. (1996) Consensus of a group of professional societies and diagnostic companies on guidelines for interim reference ranges for 14 proteins in serum based on the standardization against the IFCC/BCR/CAP Reference Material (CRM 470). International Federation of Clinical Chemistry. Community Bureau of Reference of the Commission of the European Communities. College of American Pathologists. Eur J Clin Chem Clin Biochem 34: 517-520.
23. Koch W, Latz W, Eichinger M, Roguin A, Levy AP, et al. (2002) Genotyping of the common haptoglobin Hp 1/2 polymorphism based on PCR. Clin Chem 48: 1377-1382.
24. Langlois MR, Delanghe JR (1996) Biological and clinical significance of haptoglobin polymorphism in humans. Clin Chem 42: 1589-1600.
25. Fink MP (2009) Editorial: Hemopexin: newest member of the anti-inflammatory mediator club. J Leukoc Biol 86: 203-204.
26. de Kleijn DP, Smeets MB, Kemmeren PP, Lim SK, Van Middelaar BJ, et al. (2002) Acute-phase protein haptoglobin is a cell migration factor involved in arterial restructuring. FASEB J 16: 1123-1125.
27. Cid MC, Grant DS, Hoffman GS, Auerbach R, Fauci AS, et al. (1993) Identification of haptoglobin as an angiogenic factor in sera from patients with systemic vasculitis. J Clin Invest 91: 977-985.
28. Delanghe JR, Langlois MR (2001) Hemopexin: a review of biological aspects and the role in laboratory medicine. Clin Chim Acta 312: 13-23.
29. Lin T, Kwak YH, Sammy F, He P, Thundivalappil S, et al. (2010) Synergistic inflammation is induced by blood degradation products with microbial Toll-like receptor agonists and is blocked by hemopexin. J Infect Dis 202: 624-632.
30. Liang X, Lin T, Sun G, Beasley-Topliffe L, Cavaillon JM, et al. (2009) Hemopexin down-regulates LPS-induced proinflammatory cytokines from macrophages. J Leukoc Biol 86: 229-235.
31. Kline JA, Marchick MR, Hogg MM (2009) Reduction in plasma haptoglobin in humans with acute pulmonary embolism causing tricuspid regurgitation. J Thromb Haemost 7: 1597-1599.
32. Watts JA, Lee YY, Gellar MA, Fulkerson MB, Hwang SI, et al. (2011) Proteomics of microparticles after experimental pulmonary embolism. Thromb Res 130: 122-128.
33. Zagorski J, Marchick MR, Kline JA (2009) Rapid clearance of circulating haptoglobin from plasma during acute pulmonary embolism in rats results in HMOX1 up-regulation in peripheral blood leukocytes. J Thromb Haemost 8: 389-396.
34. Nielsen MJ, Moestrup SK (2009) Receptor targeting of hemoglobin mediated by the haptoglobins: roles beyond heme scavenging. Blood 114: 764-771.